Your browser doesn't support javascript.
loading
HuR in pheochromocytomas and paragangliomas - overexpression in verified malignant tumors.
Leijon, Helena; Salmenkivi, Kaisa; Heiskanen, Ilkka; Hagström, Jaana; Louhimo, Johanna; Heikkilä, Päivi; Ristimäki, Ari; Paavonen, Timo; Metso, Saara; Mäenpää, Hanna; Haglund, Caj; Arola, Johanna.
Afiliación
  • Leijon H; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Salmenkivi K; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Heiskanen I; Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Hagström J; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Louhimo J; Department of Oral Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Heikkilä P; Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Ristimäki A; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Paavonen T; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Metso S; Genome-Scale Biology, Research Programs Unit, University of Helsinki, Helsinki, Finland.
  • Mäenpää H; Department of Pathology, Fimlab Laboratories, Tampere University Hospital, Tampere, Finland.
  • Haglund C; School of Medicine, University of Tampere, Tampere, Finland.
  • Arola J; School of Medicine, University of Tampere, Tampere, Finland.
APMIS ; 124(9): 757-63, 2016 Sep.
Article en En | MEDLINE | ID: mdl-27357268
ABSTRACT
Pheochromocytomas and paragangliomas are rare, neural crest-originating, neuroendocrine tumors. HuR is an mRNA-binding protein of the ELAV/Hu-protein family, which participates in posttranscriptional regulation of many cancer-associated genes. HuR expression has been connected with aggressive behavior of several malignancies. Cyclooxygenase-2 (COX-2) is also expressed in several malignant tumors, and its expression is regulated by HuR. Tissue microarray of 153 primary pheochromocytomas and paragangliomas was investigated for the expression of HuR and COX-2 proteins by immunohistochemistry using two different HuR antibodies (HuR19F12 and HuR3A). In these tumors, the expression of both intranuclear and cytoplasmic HuR was detectable. Increased cytoplasmic HuR expression was significantly associated with metastatic tumors. Increased COX-2 and MIB-1 expression also was associated with metastatic potential, and moreover, HuR and COX-2 expression correlated with each other. Our data suggest that increased expression of HuR protein is associated with metastatic potential of paragangliomas and pheochromocytomas, and COX-2 seems to be a target of HuR.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Paraganglioma / Feocromocitoma / Expresión Génica / Ciclooxigenasa 2 / Proteína 1 Similar a ELAV / Metástasis de la Neoplasia Límite: Humans Idioma: En Revista: APMIS Asunto de la revista: ALERGIA E IMUNOLOGIA / MICROBIOLOGIA / PATOLOGIA Año: 2016 Tipo del documento: Article País de afiliación: Finlandia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Paraganglioma / Feocromocitoma / Expresión Génica / Ciclooxigenasa 2 / Proteína 1 Similar a ELAV / Metástasis de la Neoplasia Límite: Humans Idioma: En Revista: APMIS Asunto de la revista: ALERGIA E IMUNOLOGIA / MICROBIOLOGIA / PATOLOGIA Año: 2016 Tipo del documento: Article País de afiliación: Finlandia